8251 results for "canc*"

in 22.03 milliseconds.

• Charbonneau Cancer Institute DAC

  Dac EGAC00001002096

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002160

• AA/UTUC Cancer Data Access Commitee

  Dac EGAC00001002162

• MRC Institute of Genetics and Cancer Data Access Committee

  Dac EGAC00001002163

• University of Calgary Charbonneau Cancer Institute

  Dac EGAC00001002170

• The data access committee for Detection and characterization of lung cancer using cell-free DNA fragmentomes

  Dac EGAC00001002184

• TCRseq in cancers DAC

  Dac EGAC00001002235

• Cancer Proteomics Mass Spectrometry group

  Dac EGAC00001002236

• CRMY team data access committee

  Dac EGAC00001002249

• The MITIMM Cancer Data Access Committee

  Dac EGAC00001002268

• Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

  Dac EGAC00001002276

• Data access committee breast cancer whole genome sequencing HRD

  Dac EGAC00001002286

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002291

• Genomics to select patients with metastatic breast cancer for targeted therapy DAC

  Dac EGAC00001002293

• RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors

  Dac EGAC00001002295

• EPICC: Evolutionary Predictions in Colorectal Cancer

  Dac EGAC00001002299

• OV cancer cell lines DAC

  Dac EGAC00001002307

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001002331

• MDACC Breast Cancer MoonShot Data Access Committee

  Dac EGAC00001002362

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002387

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002388

• Somatic pathogenic variants in the normal mammary gland of sporadic breast cancer patients.

  Dac EGAC00001002391

• Leeds institute of Medical Research Bladder Cancer Research Group

  Dac EGAC00001002397

• Cancer Clinical Research Trust DAC for the 23 WES samples of melanoma subtypes

  Dac EGAC00001002402

• Cancer Team Data Access Committee

  Dac EGAC00001002449

• University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee

  Dac EGAC00001002442

• Netherlands Cancer Institute - Breast Cancer Neoadjuvant chemotherapy biomarker studies

  Dac EGAC00001002452

• Cancer Sequencing Data Access Committee

  Dac EGAC00001002457

• Cancer Core Europe Data Access Commitee

  Dac EGAC00001002460

• Data Access Committee for the study "Somatic chronology of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing"

  Dac EGAC00001002479

• Whole-exome sequencing of 47 microsatellites stable Early-onset sporadic rectal cancer (EOSRC) tumors and corresponding normal samples.

  Dac EGAC00001002502

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002508

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001002510

• DAC of The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals

  Dac EGAC00001002517

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002520

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002526

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002535

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002541

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002546

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002554

• GIS - NCCS Pancreatic Cancer DAC

  Dac EGAC00001002565

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002580

• Prostate Cancer Sample Data Access Commitee

  Dac EGAC00001002586

• Laboratory of Applied Cancer Genomics team

  Dac EGAC00001002587

• EPICC: Evolutionary Predictions in Colorectal Cancer

  Dac EGAC00001002592

• Prostate Cancer Sample Data Access Commitee

  Dac EGAC00001002593

• Lung cancer cfDNA dataset DAC

  Dac EGAC00001002608

• Netherlands Cancer Institute (NKI) - Wilbert Zwart Group

  Dac EGAC00001002618

• DAC for Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

  Dac EGAC00001002644

• UCL cancer institute data access commitee

  Dac EGAC00001002659

• Salivary gland cancer TSO500 data team

  Dac EGAC00001002668

• Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR

  Dac EGAC00001002669

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001002691

• Computational Cancer Genomics and Tumor Evolution Group

  Dac EGAC00001002722

• MSKCC Colorectal Cancer Plasma WGS Data Access Comittee

  Dac EGAC00001002741

• Netherlands Cancer Institute (NKI) - Jos Jonkers Group

  Dac EGAC00001002749

• Southern African Prostate Cancer Study (SAPCS) Data Access Committee

  Dac EGAC00001002768

• Garvan/St Vincent’s Prostate Cancer Tissue and Data Access Committee

  Dac EGAC00001002769

• Breast cancer bone metastases

  Dac EGAC00001002771

• Breast cancer bone metastases

  Dac EGAC00001002772

• Netherlands Cancer Institute (NKI) - Wilbert Zwart Group

  Dac EGAC00001002782

• DAC Synergie Lyon Cancer

  Dac EGAC00001002795

• Colorectal cancer samples

  Dac EGAC00001002808

• RNAseq analysis on metastatic Colorectal Cancer xenografts samples

  Dac EGAC00001002809

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001002829

• Netherlands Cancer Institute (NKI) - Jos Jonkers Group

  Dac EGAC00001002848

• Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures

  Dac EGAC00001002865

• Cancers of Unknown Primary

  Dac EGAC00001002878

• Cancer Team Data Access Committee

  Dac EGAC00001002891

• Pancreatic cancer PDOs/CAFs DAC

  Dac EGAC00001002897

• Pan Cancer Plasma cfRNA DAC

  Dac EGAC00001002956

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001002975

• INSERM U944 Team Genome and Cancer

  Dac EGAC00001002976

• DAC Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype

  Dac EGAC00001002978

• Cancer Team Data Access Committee

  Dac EGAC00001002982

• NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer

  Dac EGAC00001003001

• Leeds Cancer Genomics

  Dac EGAC00001003010

• Ovarian Cancer Data Access Committee

  Dac EGAC00001003014

• Breast cancer bone metastases

  Dac EGAC00001003035

• Hoag Family Cancer Institute Carcinoid Multiomic Study Data Access Committee

  Dac EGAC00001003084

• DAC - Pediatric Solid Cancer

  Dac EGAC00001003088

• Cancer Genomics of the Kidney - Targeted Sequencing

  Dac EGAC00001003091

• RNAseq analysis on metastatic Colorectal Cancer xenografts samples

  Dac EGAC00001003125

• Early on-treatment changes in circulating tumor DNA fraction and response to enzalutamide or abiraterone in metastatic castration-resistant prostate cancer - Data Access Committee

  Dac EGAC00001003128

• DAC for ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

  Dac EGAC00001003141

• TCR sequencing of TIL in breast cancer data access committee

  Dac EGAC00001003173

• Cancer Genome Database Data Access Committee (CGDB_DAC)

  Dac EGAC01000000002

• Cancer Genomics Project DBA Data Access Committee

  Dac EGAC01000000005

• NOWAC blood-breast cancer Data Access Committee

  Dac EGAC01000000024

• Cancer Team Data Access Committee

  Dac EGAC00001003407

• ICGC Breast Cancer Project, RNA seq

  A comprehensive characterisation and analysis of human breast cancers through genome-wide approaches through transcriptomics.

  Dataset EGAD00001001323

• FunGeST - Functional Genomics from cancer research to personalized medicine

  Dac EGAC00001002924

• PELICAN45 and GP21 prostate cancer studies Data Access Committee

  Dac EGAC00001001309

• Human Throid Cancer and CDK4/6 inhibition Data Access Commitee

  Dac EGAC00001003446

• The CCA Genome Core is responsible for archiving the sequencing data generated by the Cancer Centre Amsterdam (CCA).

  Dac EGAC00001000181

• Netherlands Cancer Institute (NKI) - Beatriz Carvalho group

  Dac EGAC00001003134

• Netherlands Cancer Institute (NKI) - Wilbert Zwart Group

  Dac EGAC00001003257

• British Columbia Cancer Agency (BCCA), PHSAs Technology Development Office, Data Access Committee

  Dac EGAC00001002903

• British Columbia Cancer Agency (BCCA) PHSAs Technology Development Office, Data Access Committee

  Dac EGAC00001002968

• INCLIVA-CC-panel DAC

  Colon cancer targeted sequencing study contaning WBCs, primary tumor tissue and plasma samples

  Dac EGAC50000000061